Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
News Release Digital Asset Direct

ACD/Labs Announce MilliporeSigma Partnership at SMASH 2023

ACD/Labs

The collaboration represents MilliporeSigma’s joint steps toward breakthrough innovation to make research and quality control in the lab more efficient and sustainable. The new ChemisTwin™ platform combines ACD/Labs’ industry-leading NMR predictors with Millipore Sigma’s digital reference materials (dRMs). ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced a collaboration with MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company and one of the leading manufacturers/distributors of certified reference material world - wide. Through the first release version of its digital reference material (dRM) platform: ChemisTwin™, MilliporeSigma is providing scientists in quality control labs with an automated structure verification tool by NMR. This tool combines ACD/Labs’ industry-leading automated structure verification and prediction capabilities with Millipore Sigma’s expertise in high quality reference materials manufacturing. "With increasing demand for digital solutions in life sciences, we're proud to provide enabling technologies for MilliporeSigma’s digital reference material ChemisTwin™ platform,” said Andrew Anderson, Vice President of Informatics and Innovation Strategy at ACD/Labs. “Our partnership will empower scientists with a digital means for effective and robust structure verification.” “Our purpose is to shape the future of analytical testing, to make research and quality control in laboratories more efficient and sustainable. The launch of the ChemisTwin™ platform is a breakthrough innovation in our journey toward this objective, ultimately impacting life and health with science,” said Coralie Leonard, ChemisTwin™ project lead and Digital Business Model Developer, Analytical Chemistry at MilliporeSigma. "We have chosen to partner with ACD/Labs not only for their strong expertise in NMR spectral prediction and comparison, but also because they share our vision and passion to be a driver of industry change.” About ACD/Labs ACD/Labs is a leading provider of scientific software for R&D. We help customers in >94 countries around the world assemble digitized analytical, structural, and molecular information for effective decision-making, problem solving, and product lifecycle control. Our enterprise technologies enable automation of molecular characterization and facilitate chemically intelligent knowledge management. ACD/Labs provides worldwide sales and support and brings decades of experience and success helping organizations innovate and create efficiencies in their workflows. For more information, please visit www.acdlabs.com. Follow us on Twitter and LinkedIn. About the Life Science business of Merck KGaA, Darmstadt, Germany The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck KGaA, Darmstadt, Germany, generated sales of € 22.2 billion in 66 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com. Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn. All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service. Contact Details ACD/Labs Sanji Bhal +1 416-368-3435 media@acdlabs.com Allison Matthews ACDLabs@racepointglobal.com Company Website https://www.acdlabs.com/

September 18, 2023 03:00 AM Eastern Daylight Time

News Release

Good Gaming recent strategic partnership with ViaOne Services sets new course for company

Good Gaming

Good Gaming COO David Sterling joined Steve Darling from Proactive to discuss the company's latest strategic partnership and its flagship mobile game, highlighting its innovative Web3 gaming elements. Good Gaming is an interactive entertainment company that's transforming traditional gaming into digital playgrounds across a wide range of interconnected platforms. Its most recent development involves a strategic partnership with ViaOne Services, aimed at expanding its mobile gaming offerings to a broader audience, including the customer bases of Assist Wireless and enTouch Wireless, as well as various app stores. This partnership provides an exciting revenue-sharing opportunity for both Good Gaming and the ViaOne-managed companies. It is structured to include advertising and in-app purchases, creating a win-win situation for all parties involved. One of the key components of this partnership is the pre-installation of Good Gaming's games on over 100,000 mobile phones each month through enTouch and Assist Wireless. This move not only extends the reach of Good Gaming's mobile games but also ensures that their offerings are readily accessible to a large user base. Sterling also shed light on their flagship mobile game, which incorporates innovative Web3 gaming elements. These elements, related to blockchain and decentralized technologies, offer exciting possibilities for gamers, including ownership of in-game assets, provable fairness, and the potential for earning real-world value through gaming activities. With this strategic partnership and the integration of Web3 elements, Good Gaming is positioning itself at the forefront of the evolving gaming industry, offering unique experiences and opportunities for both gamers and investors alike. Contact Details Proactive Interview +1 604-688-8158 na-editorial@proactiveinvestors.com

September 14, 2023 02:03 PM Eastern Daylight Time

Video

Nextech3D.ai announces former Microsoft and Meta executive Hareesh Achi joins company

Nextech3D.AI

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) CEO Evan Gappelberg joined Steve Darling from Proactive to share news the company has added another key team member to its roster with the hiring of Hareesh Achi as its new Head of Product Operations. Gappelberg told Proactive Achi will be responsible for optimizing and streamlining operations across the company, with a focus on leveraging powerful AI technologies to enhance efficiency and drive overall performance and profitability. Achi shared his experience having worked at renowned tech giants Microsoft and Meta. Notably, he served as the leader of Meta's Reality Labs product data operations, where he oversaw the expansion of scaled operations for Meta's Reality Labs product portfolio. Before that, Achi played a pivotal role at Microsoft, overseeing the multi-billion-dollar Bing Ads operations. His extensive background and experience in operations, particularly within major tech companies, position him well to drive operational excellence at Nexttech3D.ai. Interestingly, Achi has prior experience with Nexttech3D.ai, having briefly worked with the company during the COVID period. His return to Nextech3D.ai reflects the company's commitment to assembling a top-tier team of experts in AI and technology. Hareesh Achi's appointment as Head of Product Operations underscores Nextech3D.ai's dedication to achieving operational efficiency and advancing its AI-driven solutions. With his experience at industry leaders like Microsoft and Meta, Achi is well-equipped to contribute to Nextech3D.ai's growth and success in the AI technology sector. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

September 14, 2023 01:48 PM Eastern Daylight Time

Video

News Release

ParaZero Technologies aiming to unlock full potential of UAVs

ParaZero Technologies Ltd

ParaZero Technologies Ltd (NASDAQ:PRZO) CEO Boaz Shetzer speaks to Thomas Warner from Proactive about the work the autonomous parachute safety systems developer is doing to help grow the nascent unmanned aerial vehicle (UAV) or drone market. Shetzer explains that ParaZero's products are designed to prevent fall damage to UAVs by deploying quickly when flight failure is detected. Founded by military aviation experts, the company's mission is to enhance drone industry safety, reduce operational risks, and enable advanced applications. Its flagship product, the SafeAir system, autonomously deploys a lightweight parachute in case of flight failure, ensuring a controlled descent. ParaZero supports aircraft from 1kg to 1000kg, addressing a wide range of use cases. Shetzer explained that the company's upcoming product, SmartAir Trinity, utilises AI and advanced sensors for real-time function detection and enhanced spatial awareness, akin to a human pilot. He suggested that ParaZero's global footprint and partnerships in the US, Europe, Latin America, South Korea, and India, mean it is ready to grow quickly, particularly in the Urban Air Mobility or 'air taxis' sector. Contact Details Proactive Investors +44 20 7989 0813 uk@proactiveinvestors.com

September 14, 2023 01:36 PM Eastern Daylight Time

Video

50-Provider FQHC Significantly Reduces Patient No-Show Rate by Implementing healow No-Show Prediction AI Model

eClinicalWorks

Total Health Care, Inc., a Federally Qualified Health Center (FQHC) in Baltimore, Maryland, is successfully leveraging the healow ® no-show prediction AI model to improve patient care, reduce missed appointments, and ultimately increase revenue outcomes. Total Health Care provides primary care — including dental, behavioral health, podiatry, pharmacy services, and more — to nearly 30,000 patients throughout Metropolitan Baltimore, many of whom are at or below the 200% poverty line. By identifying which patients are at a higher risk of missing appointments, Total Health Care can proactively reach out to those patients to remind them of or reschedule their appointments. Missed appointments are a significant challenge for healthcare providers, leading to lost revenue and result in negative health outcomes for patients. With the healow no-show prediction AI model, Total Health Care has reported: A significant decrease in the no-show rate of high-risk no-show patients by 34% An additional 309 appointments in 45 days from reduced no-shows “Missed appointments are a significant challenge to overcome. When the pandemic hit, digitization and optimizing systems became a priority for our organization,” said Marceé J. White, MD, FAAP, chief medical officer of Total Health Care. “As an FQHC, the healow no-show prediction AI model helps us streamline the identification and outreach process to patients likely to miss their appointment. It provides us with an opportunity to increase our patient volume, deliver quality care, and improve efficiencies for the staff.” Using AI and machine learning, the healow no-show prediction model can help practices identify patients with a high no-show probability with 90% accuracy. Once patients with a high no-show probability are identified, practices can utilize eClinicalMessenger to manage outreach efforts with voice messages, secure text messages, and email reminders. With healow Open Access ®, practices can publish open, cancelled, and last-minute rescheduled appointment slots on the practice website to avoid revenue loss, acquire new patients, and limit their waitlist. Using healow CHECK-IN ™ and healow Payment Services ™ makes the pre-visit process convenient and efficient, further reducing the rate of no-shows. These contactless solutions allow patients to check in to their appointment and pay their copay from the comfort of home. “We are excited to see Total Health Care implement the healow no-show prediction AI model to improve its overall impact on patient care,” said Girish Navani, CEO and cofounder of eClinicalWorks. “We strive to deliver FQHC’s like Total Health Care the highest quality of care to their patients and community. The introduction of the no-show model will ultimately reduce the cost of healthcare and encourage better patient outcomes." About Total Health Care Total Health Care, Inc. is a Federally Qualified Health Center (FQHC) dedicated to caring for everyone in our community—especially those who are most in need. Total Health Care is one of Maryland’s largest minority-run, nonprofit, tax-exempt community health centers and annually cares for nearly 30,000 patients throughout Metropolitan Baltimore —many at or below the 200% poverty line. For more information, visit www.totalhealthcare.org. About eClinicalWorks eClinicalWorks was founded in 1999 to help digitize paper charts for ambulatory practices. Today, eClinicalWorks leads the nation in innovation with cloud-based solutions for Electronic Health Records and Practice Management. In addition, we help ambulatory practices, specialists, health centers, urgent care facilities, and hospital systems manage their revenue cycle, patient relationships, and Population Health initiatives. More than 150,000 providers and nearly 1 million medical professionals rely upon the power and scalability of the eCW Cloud for flexible clinical documentation, better front-office workflows, and more efficient billing driven by Robotic Process Automation. We combine innovation, leading-edge technology, and a commitment to patient safety to enable practices to grow and thrive amid the challenges of 21st-century healthcare. For more information, visit www.eclinicalworks.com, follow us on Facebook and Twitter, or call (866) 888-6929. About healow healow ® is a comprehensive, EHR-agnostic, cloud-based platform for patients, practices, payers, hospitals, and health systems. healow provides Patient Relationship Management, clinical and payer insights, and state-of-the-art interoperability solutions. The PRISMA health information search engine gathers patient records from other EHRs and helps providers focus on the most clinically relevant information at the point of care. healow’s Population Health Management tools, including Remote Patient Monitoring, provide real-time data to deepen understanding of patient populations. And healow Insights automates the bidirectional exchange of data between health plans and providers to improve scores on quality measures, help control costs, and promote better medical outcomes. Learn more at plus.healow.com. Contact Details eClinicalWorks Bhakti Shah +1 508-330-6935 Bhakti.Shah@eclinicalworks.com Company Website http://www.eclinicalworks.com/

September 14, 2023 10:20 AM Eastern Daylight Time

FTN Network Acquires DFSForecast, Signs Partnership with One Week Season

FTN Network

FTN Network, a company built for delivering affordable, customizable, and highly detailed and advanced NFL data for betting, season-long fantasy, and daily fantasy, announced today that it has acquired DFSForecast, known for its Daily Fantasy Sports Lineup Builders and Advanced Data Tools. Leveraging the acquisition, FTN will provide the Optimizer to The Fantasy Footballers, and recently solidified a partnership with One Week Season to offer the DFS Optimizer to its collective userbase. Subscribers on FTNDaily.com will now be able to take advantage of DFSForecast’s lineup optimizer to create countless daily fantasy lineups in a simple and easy-to-use tool powered by FTN Data. Generated lineups can then be uploaded to one’s preferred fantasy operator, simplifying mass roster inputting. The Fantasy Footballers and One Week Season will be the first partners to use this newly acquired tool that is now part of the suite of products offered to FTN Data customers. Offered at a competitive price point compared to its competitors, FTN will look to expand its network of partners by offering this tool to those that have previously been hindered by the cost. “The 2023 football season is still very young, but FTN has seen an explosion of growth,” said FTN Network CEO Kevin Adams. “We were really impressed with the work Caleb Nelson, Sam Vitello, Adam Lewis, and the entire DFSForecast team were doing. The acquisition and incorporation of DFSForecast into our umbrella of tools offered to our customers is just another step in the journey of cementing FTN Network as the one-stop-shop for anyone when it comes to fantasy enthusiast or bettor.” "From our first meeting on, we saw FTN as a natural partner and are thrilled it's now official,” said DFSForecast Co-Founder and CEO Caleb Nelson. “We share the same data-driven approach to fantasy sports and betting. We can't wait to see how our tools add to FTN's already incredible ecosystem.” This acquisition is just one part of the burst of growth FTN Network has seen in 2023. Before the start of the 2023 football season, FTN Network announced it has signed Aaron Schatz, referred to as the founding father of football analytics, to a multi-year contract after partnering for his 2023 Football Almanac. FTN also launched “The Fantasy Football Show” on Sirius XMRadio earlier this year and has seen an incredible increase of web traffic across its network of sites. About FTN Network FTN Network is a data and entertainment network for fantasy sports and betting. Founded in 2020, FTN Network’s family of sites include Fantasy, Daily Fantasy (DFS), Betting and Data. The company has over 50 content contributors to serve the fantasy sports and betting needs of fans across key sports, including NFL, NBA, MLB, NHL, PGA, eSports, Racing and more. https://www.ftnbets.comAbout TechstarsThe Techstars worldwide network helps entrepreneurs succeed. Founded in 2006, Techstars began with three simple ideas — entrepreneurs create a better future for everyone, collaboration drives innovation, and great ideas can come from anywhere. Now we are on a mission to enable every person on the planet to contribute to, and benefit from, the success of entrepreneurs. In addition to operating accelerator programs and venture capital funds, we do this by connecting startups, investors, corporations and cities to help build thriving startup communities. Techstars has invested in more than 2,500 companies with a combined market cap of more than $220B. https://www.techstars.com About DFSForecast DFSForecast is a leading player in the fantasy sports world, known for its Daily Fantasy Sports (DFS) Lineup Builders and Advanced Data Tools. Founded in 2018, DFSForecast uses a unique methodology that uses the characteristics of previous Milly Maker winners to build innovative, customizable and easy-to-use tools for fantasy sports players of all levels. DFSForecast is led by the trio of Caleb Nelson, Sam Vitello and Adam Lewis. Contact Details Sterling A. Randle +1 801-319-6153 srandle@hotpaperlantern.com

September 14, 2023 09:03 AM Eastern Daylight Time

The Cultivated B Initiated Pre-Submission Process towards EFSA Certification for Cultivated Sausage

The Cultivated B

The Cultivated B (TCB) began discussions with the European Food Safety Authority (EFSA) and officially entered the pre-submission proces s for novel food approval of a novel or non-farmed sausage product. Subsequent to the official submission, TCB will emerge as world’s first biotech company to apply for EFSA certification for cultivated meat. This is a pivotal first step in the evolution of the cultivated meat market and establishes a viable path towards large-scale commercial production. “EFSA's Novel Food regulatory approvals process is among the most robust in the world, including a thorough and evidence-based assessment of food safety and nutritional value. For cultivated meat to become available in Europe, where this food was born, would mark a paradigm shift for the sector,” said Seth Roberts, policy manager at the Good Food Institute Europe. One of the most significant challenges in the cultivated meat sector is achieving production at the enormous volumes required by the food producer industry. In addition, food safety concerns and regulatory compliance further hinder cultivated meat from reaching consumers. TCB's early engagement with EFSA is a testament to knocking down these barriers, propelling the industry to democratize cultivated meat for the masses without compromising on quality or sustainability. "This is more than just a certification process; it’s a testament to our advanced, industrial-scale cellular agriculture technology and also a reflection of our unwavering commitment to usher in a new era of food production—one where health, taste, ethics and sustainability converge seamlessly,” said TCB CEO Dr. Hamid Noori. “The European cultivated meat sector has vast potential and considerable opportunity for growth. As this market gains prominence, our objective is to ensure consistent access to high-quality, sustainable meat for everyone. Attaining EFSA certification is a significant step in this direction.” The cell-based sausage product for which TCB seeks EFSA certification is similar to boiled sausages used in hot dogs and has been developed in close collaboration with TCB sister company The Family Butchers. It is a hybrid sausage product composed of vegan ingredients, including significant amounts of cultivated meat. Leveraging the combined expertise of both entities ensures that consumers will experience the familiar, delectable taste they love, all while benefiting from a sustainable and ethically produced product. EFSA certification is governed by a strict regulatory framework which emphasizes food safety standards. Achieving certification by EFSA for TCB’s cultivated sausage will indicate the safety of its cultivated meat products as measured by the highest European standards. It also charts the course and lays the groundwork for regulatory approvals worldwide. This strategic roadmap underscores the company’s determination to lead in the global cultivated meat industry, giving hundreds of startups in this space a path toward viable and scalable commercialization, setting new standards in food safety, innovation, and accessibility. About The Cultivated B (TCB) The Cultivated B’s multinational team of scientists develops and applies breakthrough technologies in cellular agriculture, precision fermentation and advanced bioreactor technology to enable scalable commercialization of the cellular-agriculture industry. TCB serves startups, corporations and academic research institutions within the food, pharma, cosmetics and personal care industries. With its pioneering engineering and production capabilities, TCB enables other companies to produce alternative proteins, such as cultivated meat, at industrial scale. The company’s fundamental commitment to minimizing the natural resources used paves the way toward a sustainable future, locally, regionally and globally. TCB’s research and development team is based in Germany, with manufacturing and an innovation hub based in Canada’s Toronto region. For more information, visit https://www.thecultivatedb.com and follow the company on LinkedIn. Contact Details Rainier Communications Jenna Beaucage +1 508-340-6851 tcb@rainerco.com Company Website https://www.thecultivatedb.com

September 14, 2023 08:06 AM Eastern Daylight Time

Harvest Thermal's Smart Battery HVAC Wins Major Efficiency Award at CEE ‘23

Harvest Thermal

Bay Area climate tech startup Harvest Thermal has achieved another level of recognition in the energy efficiency ecosystem. Its smart thermal battery won the Consortium of Energy Efficiency’s Integrated Home Competition award, putting it closer to top-of-mind for installers, homebuilders, and homeowners looking to dramatically reduce emissions from homes. The Integrated Home Competition recognizes newly available products that will work to achieve CEE’s vision of a comfortable, convenient, connected home. It promotes devices and systems that meet consumer expectations in terms of interoperability, reliability, and simplicity of use with an emphasis on delivering energy performance and demand savings. “It’s a proud moment for the team at Harvest Thermal to take the top prize in what is essentially Center Court of the energy efficiency world,” said CEO Jane Melia. “It’s quite an honor to earn the recognition of utility experts who must ensure the delivery of reliable, cost-effective electricity that is safe for a livable planet. ” By decarbonizing home heating and hot water, Americans can slash 10% of national emissions and ⅔ of their lifestyle emissions. Harvest’s integrated home heating and hot water solution cuts emissions by 90% compared to gas equipment and lowers bills by 30% on average. Harvest is proud to be recognized as a leading solutions provider for anyone who owns and heats their home or water. ABOUT HARVEST THERMAL Harvest Thermal is redesigning home heating and hot water for the planet. Its market-leading thermal battery system cuts carbon emissions by 90% from home heating and hot water compared to gas and 50% compared to heat pumps without storage. The cloud-connected Harvest Pod leverages software, sensors, and controls to reduce carbon emissions, and save an average of 30% off monthly heating bills. It also supports a cleaner, cheaper, and more resilient grid. Founded in 2019, Harvest Thermal has received support from the National Science Foundation, the California Energy Commission, Peninsula Clean Energy, and private investors. RECENT AWARDS NREL Industry Growth Forum’s 2023 People’s Choice Award, Edison Award for Sustainable Design, Consumer Solutions Fast Company’s Most Innovative Companies List for 2023. CEO Jane Melia was named Entrepreneur Magazine’s 100 Women of Influence 2022 ABOUT THE CONSORTIUM OF ENERGY EFFICIENCY The CEE Integrated Home is a connected, fuel-neutral, interactive, and efficient home where devices and systems effectively communicate to provide new value to customers, utility systems, and society. The Integrated Home Competition supports this vision through public promotion of commercially available solutions that are simple, reliable, well-designed, and highly functional. It provides a platform for distinguishing innovation in service to Integrated Demand-side Management objectives, including traditional energy savings. The Competition is organized by the Air-Conditioning, Heating, and Refrigeration Institute (AHRI), the American Lighting Association (ALA), the Consortium for Energy Efficiency (CEE), and UL Solutions; it is sponsored by over thirty energy efficiency utilities, trade associations, and research entities across the United States and Canada. Contact Details Harvest Thermal David Tuft +1 202-494-0813 david@harvest-thermal.com Company Website https://www.harvest-thermal.com/

September 13, 2023 12:29 PM Pacific Daylight Time

Image

xCures Platform advances progress on the White House Cancer Moonshot mission to end cancer as we know it.

xCures

xCures, a leader in data-driven cancer solutions, is thrilled to announce that its platform has been highlighted as a new commitment to deliver progress on the White House Cancer Moonshot mission – ending cancer as we know it. The xCures health-data technology platform has been designed to overcome a key challenge for many rare diseases: collecting, organizing, and standardizing comprehensive data from patients across the US. In alignment with the Cancer Moonshot Initiative’s goals to reduce cancer death rates by 50% over the next 25 years, xCures is launching an ambispective natural history study of DMG and DIPG. This study will speed up the identification of patterns that can inform more personalized treatment plans and targeted therapies. xCures will provide access without licensing fees to the data for academic and government researchers. Open access to this valuable resource will accelerate scientific breakthroughs and foster a community actively seeking a cure. “We recognize that collaboration is key to success. Our pledge extends to fostering an ongoing relationship with all stakeholders - patients, families, physicians, researchers, and advocacy organizations,” said Mika Newton, CEO of xCures. “Together, we can create a powerful collective dedicated to advancing the understanding and treatment of DMG DIPG.” DMG and DIPG patients are encouraged to sign up for the study at www.xcures.com/dmg About xCures xCures Inc. operates an AI-assisted platform that automatically retrieves medical records from all sites of care. The (unstructured) data is aggregated and organized into a powerful, always up-to-date care summary that helps cancer patients get the right therapy at the right time. The platform's portals, xINFORM for patients and xDECIDE for providers, facilitate treatment option decisions. The research portal, xUTILITY, generates Real-time, Regulatory-grade, Clinical data (RRC) for studies and decentralized trials. For more information, contact info@xcures.com or visit http://www.xcures.com. Contact Details xCures Inc Patrick van der Valk pvandervalk@xcures.com Company Website https://xcures.com

September 13, 2023 01:04 PM Eastern Daylight Time

1 ... 116 117 118 119 120 ... 495